Literature DB >> 12856997

HPLC determination of valproic acid in human serum.

P Kishore1, V Rajani Kumar, V Satyanarayana, D R Krishna.   

Abstract

A HPLC method for the determination of valproic acid (VA) in human serum using diazepam as internal standard (I.S.) is described. The eluates were separated with a C18 250 x 4.6 mm internal diameter reversed phase column maintained at a temperature of 50 degrees C. A mobile phase consisting of acetonitrile and 0.05 M phosphate buffer (pH 3.0) 45:55 v/v was used at a flow rate of 1.2 ml/min. Wavelength was switched from 360 nm to 210 nm during valproic acid retention. The method was linear over a concentration range of 20 to 160 microg/ml for valproic acid. Recovery was greater than 94% over a concentration range of 20 to 120 microg/ml and the limit of quantitation was 1 microg/ml. The intra day and inter day relative standard deviation (R.S.D.) measured at 20, 60, 80 and 120 microg/ml ranged from 1.46 to 5.34% and 0.83 to 5.03% respectively. The method is simple, rapid, accurate and sensitive and it was used for Therapeutic Drug Monitoring (TDM) in Indian epileptic patient population. The results obtained with this method correlated well with clinical practice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12856997

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  3 in total

1.  Modern methods for analysis of antiepileptic drugs in the biological fluids for pharmacokinetics, bioequivalence and therapeutic drug monitoring.

Authors:  Juseop Kang; Yoo-Sin Park; Shin-Hee Kim; Sang-Hyun Kim; Min-Young Jun
Journal:  Korean J Physiol Pharmacol       Date:  2011-04-30       Impact factor: 2.016

2.  The effect of uridine diphosphate glucuronosyltransferase (UGT)1A6 genetic polymorphism on valproic acid pharmacokinetics in Indian patients with epilepsy: a pharmacogenetic approach.

Authors:  Murali Munisamy; Manjari Tripathi; Madhuri Behari; S Raghavan; D C Jain; Barghavi Ramanujam; Karthik Arumugam; Thiyagu Rajakannan; Surulivel Rajan Mallayasamy; Vivekanandhan Subbiah
Journal:  Mol Diagn Ther       Date:  2013-10       Impact factor: 4.074

3.  Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model.

Authors:  Sharareh Eskandari; Jaleh Varshosaz; Mohsen Minaiyan; Majid Tabbakhian
Journal:  Int J Nanomedicine       Date:  2011-02-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.